News Feature in 2016

What's old is new: Reconfiguring known antibiotics to fight drug resistance

• Shraddha Chakradhar

New models: Gene-editing boom means changing landscape for primate work

• Cassandra Willyard

Shapeshifters in cancer: How some tumor cells change phenotype to evade therapy

• Amanda B Keener

Of mice and interaction: A new way to investigate complex genetic traits

• Ellie Kincaid

Picture imperfect: Going beyond imaging amyloid in Alzheimer's disease

• Ellie Kincaid

Reservoirs of resistance: To understand why antibiotics fail, geneticists chase the 'resistome'

• Shraddha Chakradhar

Trace elements: Innovative biopsy programs map how cancer spreads

• Jeanne Erdmann

Splicing solutions: Companies explore new techniques to fix splicing errors

• Shraddha Chakradhar

A second look: Efforts to repurpose old drugs against Zika cast a wide net

• Ellie Kincaid

Networking for resistance detection: FDA and CDC build repository of drug-resistant microbes

• Shraddha Chakradhar

Disease drivers: Global consortia aim to unpack genetics of diabetes and obesity

• Shraddha Chakradhar

Metabolism in mind: New insights into the 'gut-brain axis' spur commercial efforts to target it

• Roxanne Khamsi

All in one: Researchers create combination drugs for diabetes and obesity

• Shraddha Chakradhar

Overtime under the microscope: Universities prep for impact of new labor rule on labs

• Shraddha Chakradhar

Foretelling toxicity: FDA researchers work to predict risk of liver injury from drugs

• Cassandra Willyard

Saving face: The search for alternatives to life-long immunosuppression for face transplants

• Amanda B Keener

Beyond building proteins: tRNA synthetases outside of translation

• Rachel Becker

Prime pick: Researchers get selective about T cells for cancer therapy

• Shraddha Chakradhar

Out with the bad: Studying autophagy to fight infectious disease

• Leah Shaffer

Tackling the brain: Clues emerge about the pathology of sports-related brain trauma

• Amanda B. Keener